These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 8837563

  • 1. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy.
    Kono T, Morita H, Nishina T, Fujita M, Onaka H, Hirota Y, Kawamura K, Fujiwara A.
    J Am Coll Cardiol; 1996 Oct; 28(4):876-81. PubMed ID: 8837563
    [Abstract] [Full Text] [Related]

  • 2. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
    Gurbel PA, Anderson RD, MacCord CS, Scott H, Komjathy SF, Poulton J, Stafford JL, Godard J.
    Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
    Zahger D, Karagounis LA, Cercek B, Anderson JL, Sorensen S, Moreno F, Shah PK.
    Am J Cardiol; 1995 Oct 15; 76(11):749-52. PubMed ID: 7572648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
    White HD, Cross DB, Elliott JM, Norris RM, Yee TW.
    Circulation; 1994 Jan 15; 89(1):61-7. PubMed ID: 8281696
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C, Nordt TK, Peter K, Smalling RW, Runge MS, Kübler W.
    Am J Cardiol; 1996 Dec 19; 78(12A):16-9. PubMed ID: 8990406
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T, Hermens WT, Lenderink T, Molhoek GP, Grollier G, Pfisterer M, Simoons ML.
    Eur Heart J; 1996 Feb 19; 17(2):237-46. PubMed ID: 8732377
    [Abstract] [Full Text] [Related]

  • 18. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP, McCabe CH, Diver DJ, Herson S, Greene RM, Shah PK, Sequeira RF, Leya F, Kirshenbaum JM, Magorien RD.
    J Am Coll Cardiol; 1994 Dec 19; 24(7):1602-10. PubMed ID: 7963104
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.